BIMI NF Energy Saving Corp.

BOQI International Medical Announces Closing of Previously Announced Sale of Senior Secured Convertible Notes and Warrants

BOQI International Medical Announces Closing of Previously Announced Sale of Senior Secured Convertible Notes and Warrants

New York, June 04, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the closing of its previously announced sale of $4.45 million of a new series of senior secured convertible notes (the “Convertible Notes”) with an original issue discount of 19.85% and ranking senior to all outstanding and future indebtedness of the Company in a private placement to two institutional investors. Additional Convertible Notes in an aggregate original principal amount not to exceed $2,100,000 may also be issued to the institutional investors at a later date under certain circumstances. The Convertible Notes do not bear interest except upon the occurrence of an event of default.

The Convertible Notes are convertible into shares of the Company’s common stock at any time or times after the stockholder approval of the transaction is obtained, which is expected to take place at the end of July. The conversion price of the Convertible Notes is $2.59 less a 22% discount to the lowest volume weighted average price of the common stock of the Company in the prior 10 trading days before conversion, subject to a floor of $0.554 per share.

At the closing of the transaction on June 2, 2020, each institutional investor paid $1,750,000 in cash for a Convertible Note with a face amount of $2,225,000 and received a warrant to purchase 650,000 shares of common stock at an initial exercise price of $2.845. The placement agent for the Private Placement, FT Global Capital Inc., also received a warrant to purchase up to 171,845 shares of common stock at an initial exercise price of $2.845 per share, subject to increase based on the number of shares of common stock issued pursuant to the Convertible Notes.

"We are excited to have the two investors as valued partners as they share our confidence in the long-term growth of our company," said Mr. Tiewei Song, Chief Executive Officer and President of BOQI International Medical Inc. "This investment helps strengthen our financial position and provides the company with the resources to grow its business. As a consumer-centric and market-oriented company, we are more than ever committed to engaging our customers with a higher-quality, simpler and more affordable healthcare experience."

About BOQI International Medical Inc.

BOQI International Medical Inc. (formerly known as NF Energy Saving Corporation) (NASDAQ: BIMI) was founded in 2006. In February 2019, the Board of Directors of the company was reorganized following efforts led by Mr. Yongquan Bi, the company’s new Chairman, with a renewed focus on the health industry. The company is now transforming from a provider of integrated energy conservation solutions to a healthcare products provider. BOQI International Medical Inc. offers a broad range of healthcare products and related services.

Safe Harbor Statement

The statements contained herein that are not historical facts are considered “forward-looking statements.” Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” or “anticipates” or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, statements regarding the efficacy of investment in research and development are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the effect of political, economic, and market conditions and geopolitical events; the impact of COVID-19;  legislative and regulatory changes that affect our business; the availability of funds and working capital; the actions and initiatives of current and potential competitors; investor sentiment; and our reputation. We do not undertake any responsibility to publicly release any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this report. Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events, which may cause actual results to differ from those expressed or implied by any forward-looking statements. The factors discussed herein are expressed from time to time in our filings with the Securities and Exchange Commission available at . 

IR Contact:

Dragon Gate Investment Partners LLC

Tel: +1(646)-801-2803

Email:

EN
04/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NF Energy Saving Corp.

 PRESS RELEASE

BIMI Announces Receipt of a Delinquency Compliance Alert Notice from N...

BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq New York, May 20, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on May 17, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that due to its failure to timely file its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange ...

 PRESS RELEASE

BIMI Announces Receipt of a Delinquency Compliance Alert Notice from N...

BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq New York, April 23, 2024 (GLOBE NEWSWIRE) --  BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on April 19, 2024, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31,...

 PRESS RELEASE

BIMI Announces Results of 2023 Annual General Meeting of Stockholders

BIMI Announces Results of 2023 Annual General Meeting of Stockholders New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company’s 2022 Annual General Meeting of Stockholders (the “Annual Meeting”) held on Dec 29, 2023 at 11:00 a.m. at the offices of the Company, 725 5th Ave, New York, NY 10022. At the Annual General Meeting the shareholders voted and approved; 1. The election of seven dir...

 PRESS RELEASE

BIMI International Medical Inc. Announces Third Quarter 2023 Financial...

BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) --  BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months and nine months ended September 30, 2023. Revenues for the three months ended September 30, 2023 and 2022 were $2,523,193 and $4,932,479, respectively. Revenues for the nine months ended September 30, 2023 and 2022 were $11,278,496 and $10,476,224, respectively. The revenues of the Zhongshan, Qiangsheng, Eurasia, and Minka...

 PRESS RELEASE

BIMI Announces Buyback of Warrants

BIMI Announces Buyback of Warrants NEW YORK, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider, today announced its entry into material definitive agreements with certain of its warrant holders, pursuant to which BIMI agreed to buy back an aggregate of 7,066,913 warrants to purchase shares of common stock of the Company from these warrant holders. BIMI agreed to pay $0.30 for each share of common stock underlying the warrant, or an aggregate purchase price of $2,120,073.80 to the warrant holders within...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch